OSI PHARMACEUTICALS INC (OSIP) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 670 transactions totaling $463.6M, demonstrating a bullish sentiment with $407.5M in net insider flow. The most recent transaction on Jun 8, 2010 involved a transaction of 750 shares valued at $43.1K.
No significant insider buying has been recorded for OSIP in the recent period.
No significant insider selling has been recorded for OSIP in the recent period.
Based on recent SEC filings, insider sentiment for OSIP is bullish with an Insider Alignment Score of 94/100 and a net flow of $407.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at OSI PHARMACEUTICALS INC (OSIP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading OSIP stock, having executed 670 transactions in the past 90 days. The most active insider is Acqusition, Inc. Ruby (Executive), who has made 2 transactions totaling $434.9M.
Get notified when executives and directors at OSIP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 8, 2010 | Alexander Ingram Robert | Executive | Disposition | 750 | $57.50 | $43.1K | |
| Jun 8, 2010 | Klein Joseph III | Executive | Disposition | 8,500 | $57.50 | $488.8K | |
| Jun 8, 2010 | Klein Joseph III | Executive | Disposition | 5,000 | $57.50 | $287.5K | |
| Jun 8, 2010 | L. Simon Robert | Executive | Disposition | 280 | $57.50 | $16.1K | |
| Jun 7, 2010 | Inc. Ruby Acqusition, | Executive | Purchase | 6,387,295 | $57.50 | $367.3M | Large |
| Jun 7, 2010 | J. Costa Santo | Executive | Tender | 6,500 | $57.50 | $373.8K | |
| Jun 7, 2010 | M. Davies Angela | Executive | Disposition | 16 | $57.50 | $920 | |
| Jun 7, 2010 | M. Epstein David | Executive | Tender | 8 | $57.50 | $460 | |
| Jun 7, 2010 | Goddard Colin | Executive | Tender | 4,175 | $57.50 | $240.1K | |
| Jun 7, 2010 | Leung Gabriel | Executive | Tender | 910 | $57.50 | $52.3K | |
| Jun 7, 2010 | Md, Ph.d, Dsc Lundemose Anker | Executive | Tender | 1,675 | $57.50 | $96.3K | |
| Jun 7, 2010 | Mehta Viren | Executive | Tender | 375 | $57.50 | $21.6K | |
| Jun 7, 2010 | W. Niemiec David | Executive | Tender | 2,125 | $57.50 | $122.2K | |
| Jun 7, 2010 | Pinedo Herbert Md Phd | Executive | Tender | 5,342 | $57.50 | $307.2K | |
| Jun 7, 2010 | Berghuis Stevenson Katharine | Executive | Tender | 11,490 | $57.50 | $660.7K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 28 | $435.5M | 84.9% |
Sale(S) | 374 | $28.0M | 5.5% |
Tender(U) | 27 | $19.3M | 3.8% |
Disposition(D) | 24 | $15.2M | 3.0% |
Exercise(M) | 64 | $13.6M | 2.6% |
Payment(F) | 63 | $1.6M | 0.3% |
Award(A) | 90 | $6.7K | 0.0% |
Insiders at OSI PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 27 insiders making 670 transactions totaling $435.5M in purchases versus $28.0M in sales, the net buying activity of $407.5M signals strong executive confidence. Acqusition, Inc. Ruby (Executive) leads the buying activity with $434.9M in transactions across all time.